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Abstract
Objective: In-hospital mortality is an important performance measure for quality improvement,
although it requires proper risk adjustment. We set out to develop in-hospital mortality prediction
models for acute hospitalization using a nation-wide electronic administrative record system in
Japan.
Methods: Administrative records of 224,207 patients (patients discharged from 82 hospitals in
Japan between July 1, 2002 and October 31, 2002) were randomly split into preliminary (179,156
records) and test (45,051 records) groups. Study variables included Major Diagnostic Category,
age, gender, ambulance use, admission status, length of hospital stay, comorbidity, and in-hospital
mortality. ICD-10 codes were converted to calculate comorbidity scores based on Quan's
methodology. Multivariate logistic regression analysis was then performed using in-hospital
mortality as a dependent variable. C-indexes were calculated across risk groups in order to
evaluate model performances.
Results: In-hospital mortality rates were 2.68% and 2.76% for the preliminary and test datasets,
respectively. C-index values were 0.869 for the model that excluded length of stay and 0.841 for
the model that included length of stay.
Conclusion: Risk models developed in this study included a set of variables easily accessible from
administrative data, and still successfully exhibited a high degree of prediction accuracy. These
models can be used to estimate in-hospital mortality rates of various diagnoses and procedures.
Background
Numerous studies have shown that the quality of health-
care is variable and often inadequate [1-3]. Initiatives to
measure healthcare quality are an important focus for pol-
icymakers who believe that such measurements can drive
quality-improvement programs [4]. The measurement of
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healthcare quality includes process and outcome meas-
urements [5]. Outcome evaluation, including in-hospital
mortality, requires adequate risk-adjustment for different
patient mixes to make appropriate evaluations of health-
care performance [6]. Because of the clear definition of
outcome and influential patient conditions, disease-spe-
cific risk adjustment models have been developed to a cer-
tain extent in several specialties (e.g. cardiovascular
diseases) and have been available for various quality
improvement activities [7-10].
Although disease-specific risk adjustment may be useful
for quality improvement of a specific type of care, more
generic case-mix risk-standardized outcomes are required
for generalized quality evaluation across specialties [11].
In the United States, several generic case-mix measures are
available in commercial as well as non-commercial
sources (e.g. APACHE, MedisGroup, Adjusted Clinical
Group, Diagnostic Cost Groups, and the RxRisk model)
[12-14], and have been applied to categorizing patients
according to resource needs. However, many of these sys-
tems require detailed clinical and/or administrative data
that involve extensive data collection. Furthermore, most
of these case-mix measures target healthcare costs rather
than clinical outcomes.
To alleviate the burden of data collection, risk prediction
models for in-hospital mortality using administrative data
have been proposed [15,27-29]. One study used a modi-
fied version of the Charlson Index [16] as a summary
score of co-existing diagnoses. A recent international com-
parative study [17] demonstrated that the estimated
comorbidity index could predict the chance of in-hospital
death with relatively high precision (c-index of approxi-
mately 0.80), although the accuracy was suboptimal
when Japanese data were analyzed. In this study, we
developed a new prediction model for in-hospital mortal-
ity by using the same electronic dataset with national
standardized format used in the aforementioned study.
We successfully exceeded previously demonstrated predic-
tive precision by including patient demographics and
multiple administrative variables. Our study demon-
strates a potential use of the developed prediction model
for benchmarking the quality of healthcare across various
performance units with the national database.
Methods
Data source
We used a dataset provided by the Ministry of Health,
Labor, and Welfare that was originally used to evaluate a
patient classification system newly introduced to 80 uni-
versity affiliated hospitals and 2 national center hospitals
for reimbursement since 2003. The new classification sys-
tem, called Diagnosis Procedure Combination (DPC),
includes information regarding up to two major diag-
noses and up to six co-existing diagnoses. The 2003 ver-
sion of the DPC patient classification system includes 16
major diagnosis categories (MDC) and 575 disease sub-
categories which are coded in ICD-10 format. The dataset
also included additional information on patient demo-
graphics, use and types of surgical procedures, emergency/
elective hospitalization, length of stay (LOS), and dis-
charge status including in-hospital death [18-20]. The
dataset originally included information derived from hos-
pital administrative and clinical information provided by
participating hospitals to the Ministry research group,
then was made anonymous and fed back to the hospitals
for benchmarking purposes. Records for 282,064 patients
who were discharged from 82 hospitals between July 1,
2002 and October 31, 2002 were distributed and made
available for public use as of June 2008. Following the
inclusion criteria of previous studies on Hospital Stand-
ardized Mortality Ratio (HSMR) [21,22], we excluded
MDC categories with mortality rates of less than 0.5%
from our analysis. The data (n = 224,207) were then ran-
domly assigned further into two subsets that were split
80/20, one for model development and the other for val-
idation tests. The development dataset included 179,156
records and the validation dataset included 45,051
records. The datasets were made anonymous and pre-
pared by the government sector for public use. Thus, data
use was officially approved and protection of confidential
information is ensured.
Model building
We started with a prediction model by referring to the
Canadian model of HSMR as mentioned earlier [21,22].
The model includes age as the ordinal variable (under 60,
60–69, 70–79, 80–89, and 90 and over), gender, use of an
ambulance at admission, admission status (emergency/
elective), LOS, MDC, and comorbidities (model 1). We
also tested another prediction model which omitted LOS
(model 2). The rationale is that the model without LOS
should be a "pure" prediction model since LOS can be
regarded as an outcome affected by patient characteristics
and hospital care quality. Several diagnosis-specific mod-
els also consider the duration of hospitalization as a part
of outcome and do not include it as a predictor variable
[23,24]. Based on Quan's methodology [15], the ICD-10
code of each co-existing diagnosis was converted into a
score, and was summed up for each patient case to calcu-
late a Charlson Comorbidity Index score. Scores were then
classified into five categories: 0, 1–2, 3–6, 7–12, and 13
and over.
We did not include surgical treatment status as a risk
parameter because the decision of whether or not to oper-
ate on a patient with a certain medical condition would
vary and depend on the clinical judgment of each hospitalBMC Health Services Research 2008, 8:229 http://www.biomedcentral.com/1472-6963/8/229
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team. Also, surgery is not a treatment option in certain
areas of medicine.
Analytical Methods
A multivariate logistic regression analysis was performed
to predict in-hospital mortality by using the development
dataset. Tests of model performance and model fitness
were conducted using the test dataset. The prediction
accuracy of the logistic models was determined using the
c-index [25], and the c-index of the full (models 1 and 2)
and partial models were compared. A c-index value of 0.5
indicates that the model is no better than random chance
in predicting death, and a value of 1.0 suggests perfect dis-
crimination. The models were calibrated by plotting
observed versus predicted deaths based on risk. All analy-
ses were conducted with SPSS version 15.0J (SPSS Japan,
Inc).
Results
Patient Demographics in the Models
Table 1 shows in-hospital mortality by MDCs in the orig-
inal full dataset. We excluded 6 out of 15 diagnostic cate-
gories due to low mortality rates (< 0.5%). The 9
remaining diagnostic categories (n = 224,207) accounted
for almost 99% of in-hospital mortality in total acute hos-
pitalization cases. We further grouped 4 MDCs with low-
est mortality into one, resulting in 6 MDCs for the
following analysis.
Of the 179,156 patients included in the development
dataset, 53.2% were male, 35.9% had emergency status at
admission, and 8.9% used an ambulance (Table 2).
Nearly half (46.6%) of the patients were under 60 years of
age at admission, and 9.2% were 80 years or over. The
digestive system, hepatobiliary system, and pancreas




















51514 1932 3.8 31.6 31.6 6
Respiratory System 30283 1719 5.7 28.1 59.7 4
Blood and Blood 
Forming Organs and 
Immunological 
Disorders
6070 592 9.8 9.7 69.4 13
Kidney, Urinary Tract 
and Male 
Reproductive System
24415 417 1.7 6.8 76.2 11 others
Nervous System 16192 360 2.2 5.9 82.1 1





25659 246 1.0 4.0 90.7 12 others
Injuries, Burns and 
Others
19113 206 1.1 3.4 94.1 16 others








10828 47 0.4 0.8 99.6 10 excluded
Skin, Subcutaneous 
Tissue
4458 9 0.2 0.1 99.8 8 excluded
Ear, Nose, Mouth 
And Throat
14086 5 0.04 0.1 99.9 3 excluded
Pediatric disease 3497 5 0.14 0.1 100.0 15 excluded
Eye 19768 3 0.02 0.0 100.0 2 excluded
Newborn And Other 
Neonates 
(Perinatal Period)
5220 1 0.02 0.0 100.0 14 excluded
Total 282064 6117 2.2BMC Health Services Research 2008, 8:229 http://www.biomedcentral.com/1472-6963/8/229
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made up the largest share (22%) of MDCs, followed by
the respiratory system (13.5%), circulatory system
(13.1%), and nervous system (7.2%). The majority of
patients (68.6%) had a total score of 0 for the Charlson
Comorbidity Index, and only 2.5% of patients had a score
higher than 6.
Prediction Models (development dataset; n = 179,156)
Table 3 shows the in-hospital mortality prediction model
with LOS as a predictor (Model 1). Using those with a LOS
under 10 days as a reference, the odds ratio of in-hospital
death for patients with longer LOS increased linearly; the
odds ratio for patients with LOS ≥ 30 days reached 4.35
(4.01–4.72). Using the neurological MDC as a reference,
MDCs for respiratory, digestive, hepatology, and hematol-
ogy diseases showed a significantly higher odds ratio for
in-hospital death, whereas the cardiology MDC showed a
significantly lower odds ratio. Older age, gender, use of an
ambulance at admission, and emergency admission status
also showed significantly higher odds ratios. Finally,
scores for Charlson Index categories exhibited an increas-
ing linear trend in odds ratio as scores increased.
Table 4 shows the prediction model without LOS (model
2). The overall statistical significance of odds ratios was
completely identical to that of model 1, although the
magnitude was somewhat smaller for MDCs and larger for
Charlson Index categories.
Model Performance (test dataset; n = 45,051)
Table 2 compares patient characteristics in the test dataset
(n = 45,051 patients) to those of the development dataset.
The two datasets were almost identical in the distribution
of patient characteristics and case mix. In-hospital mortal-
ity rates were 2.68% and 2.76% for the development and
test datasets, respectively.
Table 5 shows the c-indexes for models 1 and 2, and those
using a partial set of predictors. C-index values were fairly
high in both models (0.841 and 0.869 for models 1 and
2, respectively). A partial model which only included
patient characteristics had a c-index of 0.727, and the
addition of MDC increased the c-index to 0.786. Further
including the comorbidity index resulted in only a mar-
ginal increase to 0.841. The model that included more
Table 2: Characteristics of patients in learning dataset and test dataset (n = 224207)
All patients (n = 224207) Learning dataset (n = 179156) Test dataset (n = 45051)
Patients % Patients % Patients %
Major Diagnostic 
Category
Nervous System 16192 7.2 12996 7.3 3196 7.1
Respiratory System 30284 13.5 24277 13.6 6007 13.3
Circulatory System 29407 13.1 23570 13.2 5837 13.0
Digestive System, 
CHepatobiliary System And 
Pancreas
51514 23.0 41125 23.0 10389 23.1
Blood and Blood Forming 
Organs and Immunological 
Disorders
6070 2.7 4829 2.7 1241 2.8
Others 90740 40.5 72359 40.4 18381 40.8
Sex male 119216 53.2 95343 53.2 23873 53.0
Age (years) under60 104341 46.5 83518 46.6 20823 46.2
60–69 47703 21.3 38148 21.3 9555 21.2
70–79 51481 23.0 41104 22.9 10377 23.0
80–89 18033 8.0 14305 8.0 3728 8.3
90- 2649 1.2 2081 1.2 568 1.3
Status emergency 80515 35.9 64282 35.9 16233 36.0
Use of an ambulance 20052 8.9 15996 8.9 4056 9.0
Total score of Charlson 
Index
score0 153710 68.6 122898 68.6 30812 68.4
score1,2 50996 22.7 40812 22.8 10184 22.6
score3–6 13742 6.1 10856 6.1 2886 6.4
score7–12 4095 1.8 3234 1.8 861 1.9
score13- 1664 0.7 1356 0.8 308 0.7
Length of stay (days) under10 109769 49.0 87979 49.1 21790 48.4
10–19 52871 23.6 42114 23.5 10757 23.9
20–29 26190 11.7 20824 11.6 5366 11.9
30- 35377 15.8 28239 15.8 7138 15.8
Hospital mortality 6047 2.7 4804 2.7 1243 2.8BMC Health Services Research 2008, 8:229 http://www.biomedcentral.com/1472-6963/8/229
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information on comorbidities showed a higher c-index.
Figures 1 and 2 demonstrate the goodness of fit regarding
the models (i.e., how well the predicted mortality rates
match the observed mortality rates among patient sub-
groups of risk). Close agreement between the predicted
and observed mortality rates with our models was seen
across various patient risk subgroups analyzed.
Discussion
The prediction model of in-hospital mortality developed
in this study is fairly consistent with observed mortality.
Results also suggest that inclusion of both comorbidity
and other demographic/clinical characteristics of patients
account for the better performance of our model com-
pared to a previously described model [17]. When admin-
istrative data are used in clinical outcomes research,
algorithms to code comorbidities are essential for defin-
ing comorbidities. Charlson comorbidity measurement
tools [16] are widely used with administrative data to
determine the burden of the disease or case-mix. Past
studies suggest that the original Charlson Index by chart
review and its adaptations for use with administrative
databases discriminate mortality similarly [15,17]. The
database used in this study assigns to each patient one to
six diagnostic codes. Counting multiple comorbidities
markedly enhanced accuracy compared to counting
Table 3: MODEL1 Hospital mortality prediction model with length of stay (n = 179156)
odds ratio 95% CI p
lower upper
Sex Male 1.20 1.13 1.28 0.00
Age under60, 60–69, 70–79, 80–89, 90- 1.47 1.43 1.51 0.00
Major Diagnostic Category Nervous System * 0.00
Respiratory System 3.97 3.47 4.55 0.00
Circulatory System 0.69 0.58 0.83 0.00
Digestive System, CHepatobiliary System And Pancreas 3.27 2.85 3.74 0.00
Blood and Blood Forming Organs and Immunological Disorders 6.77 5.73 7.98 0.00
Others 1.27 1.10 1.46 0.05
Status emergency 3.72 3.47 3.99 0.00
Use of an ambulance 1.82 1.68 1.98 0.00
Total score of Charlson Index score0 * 0.00
score1,2 1.44 1.33 1.57 0.00
score3–6 4.07 3.72 4.45 0.00
score7–12 8.25 7.32 9.29 0.00
score13- 15.05 12.86 17.61 0.00
Length of Stay under10 * 0.00
10–19 1.39 1.26 1.52 0.00
20–29 1.90 1.71 2.11 0.00
30- 4.35 4.01 4.72 0.00
Table 4: MODEL2 Hospital mortality prediction model without length of stay (n = 179156)
odds ratio 95% CI p
lower upper
Sex Male 1.19 1.12 1.26 0.00
Age under60, 60–69, 70–79, 80–89, 90- 1.58 1.54 1.62 0.00
Major Diagnostic Category Nervous System * 0.00
Respiratory System 3.40 2.98 3.89 0.00
Circulatory System 0.56 0.47 0.67 0.00
Digestive System, CHepatobiliary System And Pancreas 2.66 2.32 3.03 0.00
Blood and Blood Forming Organs and Immunological Disorders 8.09 6.88 9.52 0.00
Others 1.15 1.00 1.32 0.05
Status emergency 3.72 3.51 3.27 3.76
Use of an ambulance 1.82 1.87 1.72 2.03
Total score of harlson Index score0 * 0.00
score1,2 1.63 1.50 1.77 0.00
score3–6 5.30 4.86 5.77 0.00
score7–12 10.89 9.70 12.23 0.00
score13- 19.65 16.87 22.90 0.00BMC Health Services Research 2008, 8:229 http://www.biomedcentral.com/1472-6963/8/229
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Table 5: Hospital mortality prediction model performance metrics
C-index (95%CI)
Model 1 (with length of hospital stay) 0.869 (0.860–0.879)
Model 2 (without length of hospital stay) 0.841 (0.830–0.852)
Patients characteristics only (age, sex, status emergency, use of an ambulance) 0.727 (0.713–0.742)
Patients characteristics with MDC 0.786 (0.773–0.799)
Charlson Index only main diagnosis 0.585 (0.567–0.603)
Charlson Index with up to 4 diagnosis 0.639 (0.621–0.692)
Charlson Index with up to 6 diagnosis 0.675 (0.657–0.692)
Model1 hospital mortality prediction model calibration (n = 45051) Figure 1
Model1 hospital mortality prediction model calibration (n = 45051). * Figure 1 shows the result of the goodness of fit 
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comorbidity based on a single ICD-10 code. In addition
to comorbidities based on ICD-10 codes, MDCs were also
incorporated into our models. By including MDCs, our
model could better reflect the characteristics of major
patient conditions among all co-existing diagnoses. This
may also help to explain the improved performance of
our model compared to former prediction models (c-
index: 0.69–0.71) which incorporated only the Charlson
Index in the analysis of Japanese data [17].
Recent studies in the U.S. introduced a new risk prediction
model that includes extended administrative data with lab
test results [30,31]. Although the inclusion of detailed
clinical data may further improve prediction perform-
ance, it requires a sophisticated standardized information
system on a nationwide scale. Our prediction model
exhibited a comparable level of precision, using variables
easily accessible in conventional administrative electronic
record systems. As we demonstrated, inclusion of patient
demographics, conditions at admission, and the category
of major diagnosis with a summary score of comorbidities
may be useful and efficient in improving model perform-
ance.
In the present study, we developed two models that
include and exclude LOS. It is possible that a hospital may
promote premature discharge in order to lower in-hospi-
tal mortality, thereby adjusting for LOS to allow for a fair
Model2 hospital mortality prediction model calibration(n = 45051) Figure 2
Model2 hospital mortality prediction model calibration(n = 45051). * Figure 2 shows the result of the goodness of fit 
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comparison of hospital performance. However, the dura-
tion of hospitalization is a parameter reflecting various
factors other than in-hospital mortality risk, such as the
quality of hospital management and socio-economic con-
ditions that facilitate earlier discharge (e.g. availability of
informal care at home). Since no major difference in accu-
racy was observed between the two models, we believe
that the use of model 1, which excludes LOS, would be
more suitable to adjust for the likelihood of in-hospital
death purely due to patient conditions.
In contrast to the risk factor of age, gender did not have a
pronounced impact on mortality in our study. Previous
studies on cardiovascular surgery in Japan have also
shown that the impact of gender on in-hospital mortality
is negligible even in risk prediction models with detailed
clinical variables [9]. The odds ratio of the circulatory sys-
tem category was unexpectedly low and may require some
explanation. The average risk of cardiovascular hospitali-
zation may have been relatively low in this study because
many patients are hospitalized for cardiac catheterization
as a post-intervention evaluation in Japan. Thus, an alter-
native model that categorizes hospitalization for evalua-
tion separately may increase performance in Japanese
cases and deserves further consideration in future studies.
A number of limitations of this study are worth noting.
Exclusion of 6 low mortality MDCs might bias the per-
formance of our models. Given the c-index for model 2 (n
= 282,064) was 0.854, we believe that our model can be
useful for hospital mortality analysis in all types of dis-
ease. Nevertheless, it would be necessary to update the
hospital prediction model periodically, given that the rel-
ative importance of factors contributing to mortality may
change due to future medical innovations in diagnosis
and therapy.
Conclusion
This study is one of the few Japanese studies that verifies
and demonstrates the accuracy of in-hospital mortality
prediction models that take into account all diseases. As
standardized hospital mortality rates could be used as
indicators of quality of care and in setting national stand-
ards, risk adjustment in relation to in-hospital mortality is
thought to be useful in implementing hospital-based
efforts aimed at improving the quality of medical treat-
ment[26]. The risk model described in this study demon-
strates a good degree of discrimination and calibration. In
addition to its statistical evaluation, it is important that
the model can be readily used for risk prediction by clini-
cians in the field. A major task for the future is to consider
how to improve this model in order to make it more
detailed, its analytical qualities even more convincing,
and its use more compelling.
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